U.S. Customs Consumer
Alert
U.S. Customs Policy on Importation of Prescription Medication Drugs
Consumer Alert
The U.S. Customs Service enforces federal laws and regulations including
those of the Drug Enforcement Administration (DEA) and the Food and
Drug Administration (FDA).
A new bill was recently passed by Congress that amends a portion of
the Controlled Substances Act (21USC956(a)). This amendment allows a
United States resident to import up to 50 dosage units of a controlled
medication without a valid prescription at an international land border.
These medications must be declared upon arrival, be for your own personal
use and in their original container. However, travelers should be aware
that drug products which are not approved by the U.S. Food and Drug
Administration may not be acceptable for such importation. FDA warns
that such drugs are often of unknown quality and discourages buying
drugs sold in foreign countries. Please go to http://www.fda.gov/ora/import/purchasing_medications.htm
for further information.
The United States Federal Food, Drug, and Cosmetic Act (21 U.S.C sections
331(d), and 355(a)), which is administered by FDA, prohibits the interstate
shipment (which includes importation) of unapproved new drugs. Unapproved
new drugs are any drugs, including foreign-made versions of U.S. approved
drugs, that have not received FDA approval to demonstrate they meet
the federal requirements for safety and effectiveness. It is the importer's
obligation to demonstrate to FDA that any drugs offered for importation
have been approved by FDA.
FDA has developed guidance entitled "Coverage of Personal Importations"
which sets forth that agency's enforcement priorities with respect to
the personal importation of unapproved new drugs by individuals for
their personal use. The guidance identifies circumstances in which FDA
may consider exercising enforcement discretion and refrain from taking
legal action against illegally imported drugs. Those circumstances are
as follows:
1. the intended use (of the drug) is unapproved and for a serious
condition for which effective treatment may not be available domestically
either through commercial or clinical means;
2. there is no known commercialization or promotion to persons
residing in the U.S. by those involved in the distribution of the product
at issue;
3. the product is considered not to represent an unreasonable
risk;
4. the individual seeking to import the product affirms in writing
that it is for the patients own use (generally not more than a
3-month supply) and provides the name and address of the doctor licensed
in the U.S. responsible for his or her treatment with the product, or
provides evidence that the product is for the continuation of a treatment
begun in a foreign country.
FDA's guidance is not, however, a license for individuals to import
unapproved (and therefore illegal) drugs for personal use into the U.S
Even if all of the factors noted in the guidance are present, the drugs
remain illegal and FDA may decide that such drugs should be refused
entry or seized. The guidance represents FDAs current thinking
regarding the issues of personal importation and is intended only to
provide operating guidance for FDA personnel. The guidance does not
create any legally enforceable rights for the public; nor does it operate
to bind FDA or the public.
To avoid travel delays and to prevent possible harm from taking unsafe
or ineffective medications, residents and visitors upon arrival to or
departure from the U.S. should keep in mind the following precautions:
Do not assume that medications which are legal in foreign countries
are also approved for use in the United States. These products may be
illegal and may include addictive and dangerous substances;
Be aware that the labeled uses (conditions for which the product is
represented to be effective) for a product purchased outside the U.S.
may not be approved in the United States;
It can be dangerous to take some medications without medical supervision.
The reason why some medications are limited to prescription use in the
United States is that either they are unsafe without medical supervision
or a medical diagnosis is required to ensure that the medication is
appropriate for your condition;
Avoid purchasing any drug products that they do not approve for sale
in the U.S. (including foreign-manufactured versions of U.S. approved
drugs). FDA cannot assure that these products conform to the
manufacturing and quality assurance procedures mandated by U.S. laws
and regulations and, therefore, these products may be unsafe. In addition,
such products are illegal in the U.S. and, therefore, may be subject
to entry refusal;
Some medications which may appear to be U.S. approved drug products
may in fact be counterfeit versions of such products. (The term "counterfeit
drug' is defined as "a drug which, or the container or labeling
of which, without authorization, bears the trademark, trade name, or
other identifying mark, imprint, or device, or any likeness thereof,
of a drug manufacturer, processor, packer, or distributor other than
the person or persons who in fact manufactured, processed, packed, or
distributed such drug and which thereby falsely purports or is represented
to be the product of, or to have been packed or distributed by, such
other drug manufacturer, processor, packer, or distributor." See
21 U.S.C. 321(g)(2));
In the event you develop complications from using a medication which
require medical attention, your treatment could be delayed or made more
difficult unless there is sufficient information available about the
product, such as the generic name of the product, dosage form and strength,
and how often you need to take the product.
Possession of certain medications without a prescription from a physician
licensed in the United States may violate Federal, State, and/or local
laws;
It is important to have medications in the originally-dispensed container;
FDA's personal importation guidance provides that when bringing unapproved
drugs into the U.S. for use in treating serious or life threatening
illness, such products should be used under the care and supervision
of a U.S licensed physician. It is advisable to make available for examination
by U.S. Customs Inspectors or other appropriate government authorities
appropriate documentation of such monitoring; It is against the law
not to properly declare imported medications to U.S. Customs. When the
type of drug, the quantity, or the combination of various drugs arouse
suspicions, U.S. Customs Inspectors will ordinarily contact the nearest
FDA or DEA office for advice and will then make a final determination
about whether to release or detain the article. (See 19 U.S.C. 1499).
In addition to federal requirements, individual States may have additional
requirements covering prescription (Rx) or controlled medications. Travelers
should check with State authorities, where they reside or are traveling,
to verify that a particular prescription does in fact comply with State
regulations. In many areas, the local police department and pharmacies
can provide additional information.
Source : US Customs: http://www.customs.ustreas.gov/news/news.htm
For more detailed information on FDA's personal importation guidance,
contact your local FDA office, or check out FDA's Internet website:
http://www.fda.gov/ora/import/purchasing_medications.htm